# Steroid Avoidance, Dexamethasone, and RAGE Inhibition for Perioperative Cerebral Edema Management in High-Grade Gliomas

> **NCT07694089** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Akshitkumar MIstry** · enrollment: 80 (estimated)

## Conditions studied

- High-grade Gliomas (HGG)

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Azeliragon

## Key facts

- **NCT ID:** NCT07694089
- **Lead sponsor:** Akshitkumar MIstry
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2029-08-01
- **Final completion:** 2029-08-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-07-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07694089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07694089, "Steroid Avoidance, Dexamethasone, and RAGE Inhibition for Perioperative Cerebral Edema Management in High-Grade Gliomas". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07694089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*